GPNMB therapy to help bones regenerate
Delivery of GPNMB Therapeutics for Bone Regeneration
A GPNMB-based gel that slowly releases bone-healing proteins for people who need bone grafts or spinal fusion.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northeast Ohio Medical University NIH-funded |
| Lab location | 1 site (Rootstown, United States) |
| Project ID | NIH-11262903 on NIH RePORTER |
What this research studies
If you need a bone graft or spinal fusion, this project aims to deliver proteins called GPNMB that stimulate bone-forming cells using a temperature‑sensitive gel placed at the surgery site. The team developed a larger recombinant GPNMB protein and a small 18‑amino‑acid peptide derived from GPNMB that both promote bone growth in lab tests. Because the peptide can diffuse away after injection, researchers will use a thermoresponsive hydrogel that becomes more solid at body temperature to keep the therapy at the target site. The work includes laboratory and preclinical testing to see whether this delivery approach improves bone formation and could replace or reduce the need for autologous bone grafts.
Who could benefit from this research
Good fit: People who need bone grafts or spinal fusion, have large bone defects, or suffer from fractures that are slow to heal would be the most likely candidates.
Not a fit: Patients with active bone infection, metastatic bone disease, or those who require immediate rigid structural support may not benefit from this therapy.
Why it matters
Potential benefit: If successful, it could reduce the need to harvest bone from your own body, shorten operating time, and improve bone healing and fusion rates.
How similar studies have performed: Preclinical work, including by this team, shows GPNMB and the derived peptide can stimulate bone formation, but delivering GPNMB in a thermoresponsive hydrogel is a novel approach that has not been tested in people.
Where this research is happening
Rootstown, United States
- Northeast Ohio Medical University — Rootstown, United States (Active)
Researchers
- Principal investigator: Oyewumi, Moses O — Northeast Ohio Medical University
- Study coordinator: Oyewumi, Moses O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.